These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5379940)

  • 41. The need for a standardised cell substrate for virus vaccine production.
    Perkins FT
    Ann Ist Super Sanita; 1969; 5(1):82-9. PubMed ID: 5382315
    [No Abstract]   [Full Text] [Related]  

  • 42. Characteristics of cell culture systems: viral flora of tissue sources and tissue and medium antigens in vaccines--summary.
    Sigel MM; von Magnus H
    Natl Cancer Inst Monogr; 1968 Dec; 29():551-4. PubMed ID: 4976867
    [No Abstract]   [Full Text] [Related]  

  • 43. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines.
    van Wezel AL; van Steenis G; Hannik CA; Cohen H
    Dev Biol Stand; 1978; 41():159-68. PubMed ID: 223908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification of beta-toxin of Clostridium perfringens type C.
    Akama K; Otani S; Kameyama S
    Jpn J Med Sci Biol; 1968 Dec; 21(6):423-6. PubMed ID: 4306754
    [No Abstract]   [Full Text] [Related]  

  • 45. [Cell-containing substrates and vaccine production].
    Majer M
    Schweiz Med Wochenschr; 1970 Nov; 100(48):2086-9. PubMed ID: 5003834
    [No Abstract]   [Full Text] [Related]  

  • 46. A common antigenic substance of Vibrio parahaemolyticus. I. Isolation and purification.
    Miwtani T; Shinoda S; Nishimune H; Okada M; Takeda Y
    Biken J; 1969 Jun; 12(2):97-106. PubMed ID: 4981342
    [No Abstract]   [Full Text] [Related]  

  • 47. New trends in the preparation of cell substrates for the production of virus vaccines.
    van Wezel AL
    Prog Immunobiol Stand; 1971; 5():187-92. PubMed ID: 4349819
    [No Abstract]   [Full Text] [Related]  

  • 48. The isolation of a toxic factor from sawfly (Lophyrotoma interrupta klug) larvae.
    Leonard GJ
    Toxicon; 1972 Oct; 10(6):597-603. PubMed ID: 4665362
    [No Abstract]   [Full Text] [Related]  

  • 49. Purification and properties of staphylococcal alpha-toxin.
    Watanabe M; Kato I
    Jpn J Med Sci Biol; 1974 Apr; 27(2):86-9. PubMed ID: 4546156
    [No Abstract]   [Full Text] [Related]  

  • 50. STUDIES OF THE PRODUCTION AND PURIFICATION OF POLYOMA VIRUS. II. PURIFICATION WITH DEAE CELLULOSE CHROMATOGRAPHY.
    AMAKO K
    Kyushu J Med Sci; 1964 Feb; 15():21-8. PubMed ID: 14163649
    [No Abstract]   [Full Text] [Related]  

  • 51. [Study of heavy endotoxins and neurotoxin from smooth and rough forms of "Shigella dysenteriae": separation and purification].
    Sourek J; Digeon M; Mesrobeanu L; Raynaud M
    Ann Microbiol (Paris); 1973 Jan; 124(1):45-60. PubMed ID: 4198795
    [No Abstract]   [Full Text] [Related]  

  • 52. Partial purification and some properties of the leukocytosis-promoting material from Bordetella pertussis.
    Sato Y; Arai H
    Jpn J Med Sci Biol; 1970 Aug; 23(4):273-6. PubMed ID: 4099421
    [No Abstract]   [Full Text] [Related]  

  • 53. A. Production methods: cultivation procedures, purification of antigens.
    Raynaud M; Pekárek J
    Prog Immunobiol Stand; 1967; 3():238. PubMed ID: 5379940
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y; Arai H
    Tanpakushitsu Kakusan Koso; 1972; 17(2):139-49. PubMed ID: 4337077
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.